Predictive values may be defined as the likelihood that a result is correct. Predictive values depend on prevalence of the target analyte. NPVs of HIV tests and testing strategies are always high even ...
A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining lenacapavir, teropavimab, and zinlirvimab—has achieved high rates of viral ...
Human Immunodeficiency Virus Type 2 (HIV-2) remains a unique entity in the landscape of HIV research due to its distinct epidemiological and clinical characteristics. Predominantly confined to West ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752), which is ...
Sunlenca (lenacapavir) is a medicine that was approved by the FDA in 2022 to treat HIV in combination with other HIV medicines. Sunlenca has a unique mechanism of action and is the first medicine in ...
A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability that could lead to new therapies and bring the world closer to a ...
What are the three types of HIV tests available to patients, how do they differ, and how can patients determine the best option for them?
A recent phase 3 trial found that twice-yearly injections of Lenacapavir reduce the risk of contracting HIV by 96%. The corresponding study was published in The New England Journal of Medicine. PrEP ...
Same-day ART initiation for patients with HIV infection and tuberculosis symptoms is as effective as deferring therapy until ...
Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. A twice-yearly injection of a drug known as lenacapavir offered ...
SEATTLE — There is still no cure for HIV, but researchers have made huge strides to treat and prevent the infection. This month, the FDA approved a preventative drug that's being called a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results